Canlyniadau Chwilio - D Leibowitz

  • Dangos 1 - 19 canlyniadau o 19
Mireinio'r Canlyniadau
  1. 1
    THE EFFECT OF ETHIDIUM BROMIDE ON MITOCHONDRIAL DNA SYNTHESIS AND MITOCHONDRIAL DNA STRUCTURE IN H<scp>E</scp>L<scp>A</scp> CELLS

    THE EFFECT OF ETHIDIUM BROMIDE ON MITOCHONDRIAL DNA SYNTHESIS AND MITOCHONDRIAL DNA STRUCTURE IN H<scp>E</scp>L<scp>A</scp> CELLS gan Robert D. Leibowitz

    Cyhoeddwyd 1971
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Regulation of Protein Synthesis in HeLa Cells

    Regulation of Protein Synthesis in HeLa Cells gan Robert D. Leibowitz, Sheldon Penman

    Cyhoeddwyd 1971
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Acetylcholine receptor kinetics. A description from single-channel currents at snake neuromuscular junctions

    Acetylcholine receptor kinetics. A description from single-channel currents at snake neuromuscular junctions gan Vincent E. Dionne, Mark D. Leibowitz

    Cyhoeddwyd 1982
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Voltage-dependent gating of veratridine-modified Na channels.

    Voltage-dependent gating of veratridine-modified Na channels. gan Mark D. Leibowitz, Jeffrey B. Sutro, Bertil Hille

    Cyhoeddwyd 1986
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.

    Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway. gan Tetsuzo Tauchi, H. Scott Boswell, D Leibowitz, H E Broxmeyer

    Cyhoeddwyd 1994
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Frequent and extensive deletion during the 9,22 translocation in CML

    Frequent and extensive deletion during the 9,22 translocation in CML gan DW Popenoe, K Schaefer-Rego, JG Mears, A Bank, D Leibowitz

    Cyhoeddwyd 1986
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    CML patients in blast crisis have breakpoints localized to a specific region of the BCR

    CML patients in blast crisis have breakpoints localized to a specific region of the BCR gan K Schaefer-Rego, Henryk Dudek, Daniel Popenoe, Z Arlin, JG Mears, A Bank, D Leibowitz

    Cyhoeddwyd 1987
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Changes in restricted human cellular DNA fragments containing globin gene sequences in thalassemias and related disorders

    Changes in restricted human cellular DNA fragments containing globin gene sequences in thalassemias and related disorders gan J. Gregory Mears, Francesco Ramirez, D Leibowitz, Frank Nakamura, Arthur D. Bloom, F.I.D. Konotey-Ahulu, Arthur Bank

    Cyhoeddwyd 1978
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.

    Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. gan N. Berger, Philip J. Bailey, Chhabi Biswas, Catherine A. Cullinan, Thomas W. Doebber, Nancy S. Hayes, R Saperstein, R G Smith, Mark D. Leibowitz

    Cyhoeddwyd 1996
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (Rxr)/Peroxisome Proliferator–Activated Receptor γ (Pparγ) Heterodimer

    Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (Rxr)/Peroxisome Proliferator–Activated Receptor γ (Pparγ) Heterodimer gan Pierre Desreumaux, Laurent Dubuquoy, Sophie Nutten, Michel Peuchmaur, Walter Englaro, Kristina Schoonjans, Benoı̂t Dérijard, Béatrice Desvergne, Walter Wahli, Pierre Chambon, Mark D. Leibowitz, Jean–Frédéric Colombel, Johan Auwerx

    Cyhoeddwyd 2001
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Rosiglitazone Induction of Insig-1 in White Adipose Tissue Reveals a Novel Interplay of Peroxisome Proliferator-activated Receptor γ and Sterol Regulatory Element-binding Protein in the Regulation of Adipogenesis

    Rosiglitazone Induction of Insig-1 in White Adipose Tissue Reveals a Novel Interplay of Peroxisome Proliferator-activated Receptor γ and Sterol Regulatory Element-binding Protein i... gan Heidi R. Kast-Woelbern, Sharon Dana, Rosemary M. Cesario, Li Sun, Louise Y. de Grandpre, Mason E. Brooks, Deborah L. Osburn, Anne Reifel‐Miller, Kay Klausing, Mark D. Leibowitz

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort

    Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort gan Benjamin D. Leibowitz, Bonnie V. Dougherty, Joshua S. K. Bell, Joshuah Kapilivsky, Jackson Michuda, Andrew J. Sedgewick, Wesley Munson, Tushar A. Chandra, Jonathan R. Dry, Nike Beaubier, Catherine Igartua, Timothy Taxter

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor

    Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor gan Thierry Claudel, Mark D. Leibowitz, Catherine Fiévet, Anne Tailleux, Brandee Wagner, Joyce J. Repa, Gérard Torpier, Jean‐Marc A. Lobaccaro, James R. Paterniti, David J. Mangelsdorf, Richard A. Heyman, Johan Auwerx

    Cyhoeddwyd 2001
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Down-regulation of the Expression of the Obese Gene by an Antidiabetic Thiazolidinedione in Zucker Diabetic Fatty Rats and db/db Mice

    Down-regulation of the Expression of the Obese Gene by an Antidiabetic Thiazolidinedione in Zucker Diabetic Fatty Rats and db/db Mice gan Bei Zhang, Michael P. Graziano, Thomas W. Doebber, Mark D. Leibowitz, Sylvia White-Carrington, Deborah Szalkowski, Patricia J. Hey, Margaret Wu, Catherine A. Cullinan, Philip J. Bailey, Bettina Löllmann, Robert Frederich, Jeffrey S. Flier, Catherine D. Strader, Roy G. Smith

    Cyhoeddwyd 1996
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Activation of PPARδ alters lipid metabolism in db/db mice

    Activation of PPARδ alters lipid metabolism in db/db mice gan Mark D. Leibowitz, Catherine Fiévet, Nathalie Hennuyer, Julia Peinado‐Onsurbe, Hélène Duez, Joel P. Berger, Catherine A. Cullinan, Carl P. Sparrow, Joanne Baffic, Gregory D. Berger, Conrad Santini, Robert W. Marquis, Richard L. Tolman, Roy G. Smith, David E. Moller, Johan Auwerx

    Cyhoeddwyd 2000
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Novel Peroxisome Proliferator-activated Receptor (PPAR) γ and PPARδ Ligands Produce Distinct Biological Effects

    Novel Peroxisome Proliferator-activated Receptor (PPAR) γ and PPARδ Ligands Produce Distinct Biological Effects gan Joel P. Berger, Mark D. Leibowitz, Thomas W. Doebber, Alex Elbrecht, Bei Zhang, Gaochou Zhou, Chhabi Biswas, Catherine A. Cullinan, Nancy S. Hayes, Ying Li, Michael Tanen, John Ventre, Margaret Wu, Gregory D. Berger, Ralph Mosley, Robert W. Marquis, Conrad Santini, Soumya P. Sahoo, Richard L. Tolman, Roy G. Smith, David E. Moller

    Cyhoeddwyd 1999
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

    Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea gan Abdulraheem Yacoub, John Mascarenhas, Heidi E. Kosiorek, Josef T. Prchal, Dmitry Berenzon, Maria R. Baer, Ellen K. Ritchie, Richard T. Silver, Craig M. Kessler, Elliott F. Winton, Maria Chiara Finazzi, Alessandro Rambaldi, Alessandro M. Vannucchi, D Leibowitz, Damiano Rondelli, Murat O. Arcasoy, Rosalind Catchatourian, Joseph Vadakara, Vittorio Rosti, Elizabeth O. Hexner, Marina Kremyanskaya, Lonette Sandy, Joseph Tripodi, Vesna Najfeld, Noushin Farnoud, Elli Papaemmanuil, Mohamed E. Salama, Rona Singer-Weinberg, Raajit K. Rampal, Judith D. Goldberg, Tiziano Barbui, Ruben A. Mesa, Amylou C. Dueck, Ronald Hoffman

    Cyhoeddwyd 2019
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    A pan-cancer organoid platform for precision medicine

    A pan-cancer organoid platform for precision medicine gan Brian M. Larsen, Madhavi Kannan, Lee Langer, Benjamin D. Leibowitz, Aïcha BenTaieb, Andrea Cancino, Igor Dolgalev, Bridgette E. Drummond, Jonathan R. Dry, Chi-Sing Ho, Gaurav Khullar, Benjamin A. Krantz, Brandon Mapes, Kelly E. McKinnon, Jessica Metti, Jason Perera, Tim Rand, Verónica Sánchez-Freire, Jenna Shaxted, Michelle M. Stein, Michael Streit, Yi‐Hung Carol Tan, Yilin Zhang, Ende Zhao, Jagadish Venkataraman, Martin C. Stumpe, Jeffrey A. Borgia, Ashiq Masood, Daniel V.T. Catenacci, Jeremy Mathews, Demirkan Gursel, Jian-Jun Wei, Theodore H. Welling, Diane M. Simeone, Kevin P. White, Aly A. Khan, Catherine Igartua, Ameen A. Salahudeen

    Cyhoeddwyd 2021
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

    A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia gan John Mascarenhas, Heidi E. Kosiorek, Josef T. Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub, Claire Harrison, Mary Frances McMullin, Alessandro M. Vannucchi, Joanne Ewing, Casey L. O’Connell, Jean‐Jacques Kiladjian, Adam J. Mead, Elliott F. Winton, D Leibowitz, Valerio De Stefano, Murat O. Arcasoy, Craig M. Kessler, Rosalind Catchatourian, Damiano Rondelli, Richard T. Silver, Andrea Bacigalupo, Arnon Nagler, Marina Kremyanskaya, Max F. Levine, Juan Arango Ossa, Erin McGovern, Lonette Sandy, Mohamad E. Salama, Vesna Najfeld, Joseph Tripodi, Noushin Farnoud, Alexander Penson, Rona Singer Weinberg, Leah Price, Judith D. Goldberg, Tiziano Barbui, Roberto Marchioli, Gianni Tognoni, Raajit K. Rampal, Ruben A. Mesa, Amylou C. Dueck, Ronald Hoffman

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: